- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06157723
Economic Burden of Knee Osteoarthritis in Talavera de la Reina Health Area.
Economic Burden of Knee Osteoarthritis in Talavera de la Reina Health Area: a Descriptive Retrospective Observational Study Using Database
This is a descriptive retrospective study of individuals affected with knee osteoarthritis. The aim of this study is to describe the sociodemographic and clinical characteristics of individuals diagnosed with knee osteoarthritis within a specific health area, as well as to assess the economic impact of this condition on the healthcare system. To achieve this, medical records will be reviewed, and the following data will be collected:
Sociodemographic and clinical participant data. Healthcare resource use. Clinical burden. Up to 400 subjects will be enrolled in the Talavera de la Reina Health Area (Toledo, Spain).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a multicenter, observational, retrospective study focusing on individuals diagnosed with knee osteoarthritis. This study will be conducted in the Talavera de la Reina Health Area (Toledo, Spain). Participants will be identified through the codes assigned in the electronic database associated with knee osteoarthritis.
Data will be collected from the initial radiologic diagnostic moment to December 31, 2019. For each participant enrolled, data from medical records will be collected and entered onto an electronic case report form (REDCap).
The sociodemographic and clinical data related to the pathology will be collected, including age, weight, height, duration of the condition, and occupational activity.
The following data will be considered as direct healthcare costs: the number of visits in primary and specialized care, diagnostic tests, surgical interventions, and emergencies at both health centers and hospitals. In addition, pharmacotherapy, rehabilitation number of sessions, and work absences (temporary and permanent) will be registered.
For cost estimation, a prevalence-based approach and a bottom-up estimation will be employed in the monetary valuation of healthcare resources, utilizing official sources.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Juan Avendaño Coy, PhD
- Phone Number: 5423 925268800
- Email: juan.avendano@uclm.es
Study Contact Backup
- Name: Natalia Comino Suárez, PT, MSc
- Email: natalia.comino@uclm.es
Study Locations
-
-
Toledo
-
Talavera De La Reina, Toledo, Spain, 45600
- Recruiting
- Hospital Nuestra Señora del Prado
-
Contact:
- Javier Aceituno Gómez, PhD
- Email: javier.aceituno@uclm.es
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients ≥18 years old.
- Diagnosed with unilateral or bilateral knee osteoarthritis according to the clinical criteria of the American College of Rheumatology.
- Radiographic imaging diagnosis based on the Kellgren & Lawrence (K-L) classification.
Exclusion Criteria:
- No available X-ray.
- Pre-existing neurological diseases before the diagnostic date (stroke, Parkinson's, multiple sclerosis, ALS).
- Connective tissue disorders (Ehlers-Danlos, Marfan). Secondary cause of osteoarthritis or severe osteoarthritis (ACL tears, severe traumas, infections, or sepsis).
- Inflammatory arthropathy (any type of arthritis).
- Genetic disorders with a higher risk of developing arthropathies (Down syndrome).
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Knee osteoarthritis participants
Participants who are registered in the Health system electronic database, with a clinical and radiographic diagnostic of knee osteoarthritis.
Approximately a total of 400 participants will be enrolled in the study.
|
Data related to the knee osteoarthritis will be extracted from patients' medical records: The sociodemographic and clinical participants' characteristics: age, weight, height, duration of the condition, and occupational activity. The healthcare costs: the number of visits in primary and specialized care, diagnostic tests, surgical interventions, and emergencies at both health centers and hospitals, physical rehabilitation and number of sessions. Charlson Comorbidity Index (CCI). Pharmacotherapy (type of drug and dose). Work absences (temporary and permanent).
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Healthcare resource use
Time Frame: Data will be collected from from the initial radiologic diagnosis registered in the electronic database to December 31, 2019.
|
Healthcare resource use will be collected from medical records. The data will be collected by four collaborators from the healthcare system, filling out electronic forms on REDCap. The health direct cost will be the following: The number of visits in primary and specialized care and type of health professional, number and type of surgical interventions, and number of emergencies at both health centers and hospitals. Type and number of diagnostic tests. Pharmacotherapy (type of drug and dose). The number of sessions of physical therapy. |
Data will be collected from from the initial radiologic diagnosis registered in the electronic database to December 31, 2019.
|
Participants sociodemographic characteristics
Time Frame: Data will be collected from from the initial radiologic diagnosis registered in the electronic database to December 31, 2019.
|
Age, weight, height and work activity.
|
Data will be collected from from the initial radiologic diagnosis registered in the electronic database to December 31, 2019.
|
Participant clinical characteristics
Time Frame: Data will be collected from from the initial radiologic diagnosis registered in the electronic database to December 31, 2019.
|
Severity of knee osteoarthritis with the radiographic Kellgren and Lawrence classification. Disease progression time. |
Data will be collected from from the initial radiologic diagnosis registered in the electronic database to December 31, 2019.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Charlson Comorbidity Index (CCI)
Time Frame: Data will be collected from from the initial radiologic diagnosis registered in the electronic database to December 31, 2019.
|
Mortality proGnostic with the Charlson Comorbidity Index (CCI)
|
Data will be collected from from the initial radiologic diagnosis registered in the electronic database to December 31, 2019.
|
Work absences
Time Frame: Data will be collected from from the initial radiologic diagnosis registered in the electronic database to December 31, 2019.
|
Number of work absences (temporary and permanent) related with knee osteoarthritis
|
Data will be collected from from the initial radiologic diagnosis registered in the electronic database to December 31, 2019.
|
Physical therapy treatment
Time Frame: Data will be collected from from the initial radiologic diagnosis registered in the electronic database to December 31, 2019.
|
To know the number of subjects who received the rehabilitation program for knee osteoarthritis.
|
Data will be collected from from the initial radiologic diagnosis registered in the electronic database to December 31, 2019.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Burden Knee Osteoarthritis
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Novartis PharmaceuticalsRecruitingSymptomatic Knee OsteoarthritisUnited States, Spain, Hungary, Argentina, Germany, Czechia, Belgium, Romania, Slovakia
-
University of BathUniversity of Oxford; 3D Metal Printing Ltd; Versus ArthritisRecruitingMedial Knee OsteoarthritisUnited Kingdom
-
Laval UniversityFonds de la Recherche en Santé du Québec; Natural Sciences and Engineering... and other collaboratorsCompleted
-
Max Biocare Pty. Ltd.Completed
Clinical Trials on None (Observational study)
-
Taysha Gene Therapies, Inc.Withdrawn
-
AstraZenecaRecruitingNon-Small Cell Lung CancerUnited States
-
AstraZenecaRecruitingAsthmaCanada, Belgium, Italy, Switzerland, Germany, Austria, Sweden, Denmark, Israel
-
Vanderbilt University Medical CenterUniversity of California, Los AngelesRecruitingTourette SyndromeUnited States
-
Major Extremity Trauma Research ConsortiumRecruiting
-
University of ExeterCompleted
-
Medialis Ltd.Metabolic Support UKCompletedX-linked Hypophosphatemia (XLH)United Kingdom
-
PfizerCompletedTransthyretin Amyloidosis | Transthyretin Gene MutationsUnited States, France, Spain, Taiwan, Israel, Korea, Republic of, Denmark, Canada, Netherlands, Japan, Sweden, Brazil, Mexico, Argentina, Portugal, Belgium, Bulgaria, Cyprus, Germany, Italy, Malaysia, Romania, Saudi Arabia, Turkey, United...
-
German Cancer Research CenterActive, not recruitingCancer-related FatigueGermany
-
UNC Lineberger Comprehensive Cancer CenterAmerican Cancer Society, Inc.Completed